anmelden
FTSE All-Share
5.479,78
PKT
-90,59
PKT
-1,63
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.01.22 | Unilever Overweight | Barclays Capital | |
| 14.01.22 | Rio Tinto Outperform | Credit Suisse Group | |
| 14.01.22 | Vodafone Group Buy | UBS AG | |
| 14.01.22 | BP Overweight | JP Morgan Chase & Co. | |
| 14.01.22 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 14.01.22 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 13.01.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 13.01.22 | Vodafone Group Outperform | Bernstein Research | |
| 13.01.22 | London Stock Exchange (LSE) Buy | Goldman Sachs Group Inc. | |
| 13.01.22 | Rio Tinto Equal Weight | Barclays Capital | |
| 13.01.22 | Rio Tinto Neutral | JP Morgan Chase & Co. | |
| 12.01.22 | Diageo Outperform | Credit Suisse Group | |
| 12.01.22 | HSBC Neutral | JP Morgan Chase & Co. | |
| 11.01.22 | Diageo Outperform | Credit Suisse Group | |
| 11.01.22 | HSBC Hold | Jefferies & Company Inc. | |
| 11.01.22 | Lloyds Banking Group Buy | Jefferies & Company Inc. | |
| 11.01.22 | Barclays Buy | Jefferies & Company Inc. | |
| 11.01.22 | BP Overweight | Barclays Capital | |
| 10.01.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 10.01.22 | BAT Overweight | Barclays Capital | |
| 10.01.22 | Vodafone Group Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.01.22 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 07.01.22 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.01.22 | GSK Buy | Goldman Sachs Group Inc. | |
| 07.01.22 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 07.01.22 | HSBC Outperform | RBC Capital Markets | |
| 07.01.22 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.01.22 | Rio Tinto Sell | UBS AG | |
| 06.01.22 | Diageo Market-Perform | Bernstein Research | |
| 06.01.22 | Unilever Buy | Jefferies & Company Inc. | |
| 06.01.22 | BP Sector Perform | RBC Capital Markets | |
| 06.01.22 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 06.01.22 | Diageo Underperform | RBC Capital Markets | |
| 06.01.22 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 05.01.22 | Barclays Buy | UBS AG | |
| 04.01.22 | BAT Outperform | RBC Capital Markets | |
| 04.01.22 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 04.01.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.01.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 22.12.21 | Diageo Market-Perform | Bernstein Research |